Lin Zhonggang agreed to acquire a 43.5% stake in Heilongjiang Thalys Medical Technology Co., Ltd. from Thalys Medical Technology Group Corporation for CNY 1.5 million

Thalys Medical Technology Group Corp, formerly Thalys Medical Technology Inc, is a China-based company principally engaged in the provision of intensified distribution business and simple sales business and the research, design, manufacture and distribution of independent in vitro diagnostic products. Its product type includes purchased reagents and consumables, self-produced reagents and consumables, as well as purchased equipment. The Company mainly operates its business in domestic markets, with Hubei, Hunan, Jiangsu, Henan and Shanghai province as its major markets.